| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3142364
Max Phase: Preclinical
Molecular Formula: C26H51N3O5
Molecular Weight: 485.71
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCC(O)[C@H](CCC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)C(C)C
Standard InChI: InChI=1S/C26H51N3O5/c1-10-12-13-14-16-20(30)19(15-11-2)27-23(31)21(17(3)4)28-24(32)22(18(5)6)29-25(33)34-26(7,8)9/h17-22,30H,10-16H2,1-9H3,(H,27,31)(H,28,32)(H,29,33)/t19-,20?,21-,22-/m0/s1
Standard InChI Key: IZHJRKJUNADDBG-UZVDJONISA-N
Associated Targets(Human)
Pepsin A 59 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 485.71 | Molecular Weight (Monoisotopic): 485.3829 | AlogP: 4.29 | #Rotatable Bonds: 15 |
| Polar Surface Area: 116.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.70 | CX Basic pKa: | CX LogP: 4.98 | CX LogD: 4.98 |
| Aromatic Rings: 0 | Heavy Atoms: 34 | QED Weighted: 0.26 | Np Likeness Score: 0.28 |
References
| 1. Kratzel M, Hiessböck R, Bernkop-Schnürch A.. (1998) Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues., 41 (13): [PMID:9632367] [10.1021/jm980015w] |
Source
Source(1):